Compound Chinese medicine prepn for treating muscular atrophy and amyasthenia and its prepn process

A muscle atrophy and muscle weakness technology, applied in muscle weakness - traditional Chinese medicine compound preparation and preparation of atrophy in traditional Chinese medicine, in the field of treatment of hereditary muscle atrophy, can solve problems such as difficulty in treatment and curative effect, no definite curative effect, etc., and achieve product price Inexpensive, no toxic side effects, easy to accept effects

Inactive Publication Date: 2004-09-08
夏玉卿 +2
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This brings great difficulties to the treatment and curative effect of this disease
Since this century, many scholars have made a lot of efforts t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0097] Example 1: Wei, male, 7 years old, from Xuzhou City, Anhui Province. First visit date: November 18, 1993, medical record number 01918.

[0098] Chief complaint: progressive aggravation of limb weakness for 2 years. Medical history: The child gave birth to her third child at full term. She was able to walk at 21 months, but her gait was unstable. After 2.5 years old, she was prone to fall when walking on flat ground. She was unable to walk and swayed from side to side when walking. , had to support the ankle, and then the knee to stand up, and found that the calf muscles gradually thickened and hardened. He went to Nanjing and Shanghai Medical College for examination and was diagnosed as "progressive muscular dystrophy". No improvement after drug treatment, the state of an illness gradually worsened, and the child's two stools were normal.

[0099] Physical examination: T36.4 ℃, R24 beats / min, body weight 21Kg, pale complexion, thin and small body shape, no abnormalit...

example 2

[0109] Example 2: Chen, 6 years old, from Si County, Anhui Province. First visit period: November 15, 1993, medical record number 0417.

[0110] Chief complaint: weakness of both lower limbs, easy to fall for more than a year. Medical history: The child gave birth to her second child at full term. She was able to walk at 17 months, but she was weak and slower than normal children. She often fell when walking on flat ground. She swayed from side to side in a "duck gait" when walking, and her waist and knees were sore and weak. It is difficult to go upstairs or climb a slope, and you have to support it with your hands. You can't stand while squatting, and you have to use your hands to support your ankles and knees to stand up. After examination at the local hospital, he was diagnosed as 'progressive muscular dystrophy'; then he went to Beijing Children's Hospital for examination: the electromyography showed myogenic damage, and no treatment was given. The child's diet is norma...

Embodiment 1

[0170] Recipe: Tomorrow Ma 2500g Scorpion 2500g Centipede 2500g Niu Xi 1200g Chuan Duan 1200g Dilong 1200g Eucommia Charcoal 1200g

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention is compound Chinese medicine preparation for treating muscular atrophy and amyasthenia and its preparation process. The compound Chinese medicine preparation is prepared with gastrodia tuber, scorpion, centipede, earthworm, achyranthes root, teasel root and eucommia bark charcoal, and through the process of washing with drinking water, stoving at 50 deg.c, milling into fine powder of 100-300 mesh, mixing through stirring and capsulizing 0.25 g each. Clinical application proves its high effective rate.

Description

Technical field: [0001] The invention relates to a Chinese medicine compound preparation and a preparation method, in particular to a Chinese medicine compound preparation and a preparation method for treating hereditary muscular atrophy and myasthenia—the atrophy of traditional Chinese medicine. Background technique: [0002] Muscle atrophy and muscle weakness—atrophy in traditional Chinese medicine is an X-chromosomal disease with recessive inheritance. Most of them are males, more common in children, and the age of onset is 2-3 years old. Pseudohypertrophy and muscle atrophy started at the waist, and walking disorders (duck steps, falls) progressed rapidly from the early stage. [0003] At present, many scholars from all over the world are exploring the disease, but it is still unclear. Because of the slow course of the disease, some types last as long as a normal lifespan. This brings great difficulty to the treatment and curative effect of primary disease. Since thi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K9/10A61K9/16A61K9/20A61K9/48A61P21/04
Inventor 夏玉卿郭玉钦张鹏毅
Owner 夏玉卿
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap